non-nucleoside reverse transcriptase inhibitor
HIV Drugs in the Pipeline: Expected Approvals for 2018
Pharmaceutical companies are looking at antiretroviral therapy regimens that are easier on patients with HIV.
DECEMBER 29, 2017
FDA Approves Juluca, First 2-Drug Regimen for HIV
Juluca is the first complete treatment regimen containing only two drugs for the maintenance treatment of HIV-1 ...
NOVEMBER 22, 2017
Load more